Celldex Therapeutics buy Citigroup Inc.
Start price
07.10.24
/
50%
€28.20
Target price
07.10.25
€63.74
Performance (%)
-1.42%
Price
07.10.24
€27.80
Summary
This prediction is currently active. With a performance of -1.42%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 07.10.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Celldex Therapeutics | -1.42% |
iShares Core DAX® | -1.958% |
iShares Nasdaq 100 | 0.272% |
iShares Nikkei 225® | 0.377% |
iShares S&P 500 | 0.370% |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $70.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat